The page lists 26 projects related to the topic "immunotherapeutic".
# | |||
---|---|---|---|
1 | MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) | 2015 |
2 | EpiNKT | Transcriptional and epigenetic control of innate-like T lymphocyte development | 2015 |
3 | EVIDENT | Ebola Virus Disease - correlates of protection, determinants of outcome, and clinical management | 2014 |
4 | ISPIC | Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome | 2016 |
5 | CerviVax | New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia | 2015 |
6 | NEUTRO-LILR | Leukocyte immunoglobulin-like receptors (LILRs) on neutrophils | 2016 |
7 | iGEMMdev | Development and Characterisation of New Immunogenic GEMMs of Lung Cancer | 2017 |
8 | CHEMCHECK | CHECKPOINTS IN CHECK: Novel Chemical Toolbox for Local Cancer Immunotherapy | 2016 |
9 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
10 | SENSIT | Sensitivity of human tumors to T cell attack | 2017 |
11 | CANCER | Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life | 2018 |
12 | ImmunoFit | Harnessing tumor metabolism to overcome immunosupression | 2018 |
13 | UTILIUM | Unraveling The Immune Landscape In Uveal Melanoma | 2018 |
14 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
15 | PaSION | A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy | 2018 |
16 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
17 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
18 | I-DireCT | Immune DIREcted and Cancer-selective immunoTherapy | 2019 |
19 | STIMUNO | Searching for novel strategies improving cancer immunotherapy | 2019 |
20 | ImmunoMECH | High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment | 2019 |
21 | Need2immune | Personalized liposomal cancer vaccines within days by rapid formulation screening | 2019 |
22 | FRC BioEnergetics | Functional dissection of metabolic checkpoints in lymph node fibroblastic reticular cells | 2020 |
23 | PeptiCHIP | PEPTICHIP: Streamlined identification of tumour neoantigens for personalised anti-cancer immunotherapy | 2019 |
24 | ImmunoSep | Personalized immunotherapy in sepsis: a precision medicine based approach | 2020 |
25 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
26 | Immuno-Predictor | Mechanical Biomarkers for Prediction of Cancer Immunotherapy | 2020 |